Home » Nkam Elvis scores first goal in Turkey

Nkam Elvis scores first goal in Turkey

by Lesley Ngwa
0 comment

MALATYA BÜYÜKSEHIR BELEDiYESPOR KULÜP BASKANLIGI new signing Nkam Elvis whose signing was announced by this online news portal, 2021 Best player of Cameroon Amputee football league is already making a name for himself in the books of the clubs.

Less than a month after joining the club Vishow as he is fondly called has featured in two league games of the season changing the position of the club with his brilliant performance and a goal.

Vishow’s first game pitted his side against Konya Amputee Football Club, Sunday December 18, 2022 where his side picked up their first point of the season after four days of play in a virgin tie.

The second game counting for match day five, the versatile player netted his first goal against BAGCILAR ENGELLiLER Amputee Football Club Sunday December 25, 2022 on away soil. He opened scores for the team before it was equalized from the penalty spot by their opponent.

In two games featured for the club, Nkam Elvis has help his side pick up two points from two draws and moved two places better. With such impact and just in two games, coupled with the fact that the league is still young, there is hope by the end of the season, MALATYA BÜYÜKSEHIR BELEDiYESPOR KULÜP BASKANLIGI will be better placed.

Malatya is ranked 12 on the classification table out of 14 teams after match day five with two points.

You can also read;

🇨🇲🇹🇷Amputee: Nkam Elvis pens with Turkish outfit

https://kick442.com/amputee-nkam-elvis-pens-with-turkish-outfit/


Copyright 2022©️ kick442.com.

All rights reserved. This material and any other digital content on this platform may not be reproduced, published, broadcasted, written in full or in parts, without a written permission from our management.

This site is not responsible for the content displayed by external sites.

Related Articles

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

You cannot copy content of this page

en_USEnglish